Migraine: Epidemiology, Burden, and Comorbidity.
Neurol Clin. 37: 631-649Pediatric Migraine.
Neurol Clin. 27: 481-501Vos T. Abajobir A.A. Abbafati C. et al.Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.
Lancet. 390: 1211-1259Steiner T.J. Stovner L.J. Vos T. et al.Migraine is first cause of disability in under 50s: will health politicians now take notice?.
J Headache Pain. https://doi.org/10.1186/s10194-018-0846-2Allain-Regnault M. Bwibo N.O. Chigier E.Young people’s health - A challenge for society.
World Heal Organ - Tech Rep Ser. 731: 1-117Hershey A.D. Powers S.W. Vockell A.L.B. et al.Development of a patient-based grading scale for PedMIDAS.
Cephalalgia. 24: 844-849New daily persistent headache: A systematic review on an enigmatic disorder.
J Headache Pain. https://doi.org/10.1186/s10194-019-1022-zNew daily persistent headache (NDPH) triggered by a single Valsalva event: A case series.
Cephalalgia. 39: 785-791New Daily Persistent Headache Is Most Likely to Begin at the Start of School.
J Child Neurol. 31: 864-868Strong E. Pierce E.L. Langdon R. et al.New Daily Persistent Headache in a Pediatric Population.
J Child Neurol. 36: 888-893Ghosh A. Silva E. Burish M.J.Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis.
Cephalalgia. 41: 1382-1395Oskoui M. Pringsheim T. Holler-Managan Y. et al.Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
Neurology. 93: 487-499Short-term treatment of Migraine in Children and Adolescents.
JAMA. 174: 789-790Hämäläinen M.L. Hoppu K. Valkeila E. et al.Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study.
Neurology. 48: 103-107Lipton R.B. Munjal S. Brand-Schieber E. et al.Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
Headache. 60: 58-70Cady R. Nett R. Dexter K. et al.Treatment of chronic migraine: A 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Headache. 54: 80-93Ferrari M.D. Roon K.I. Lipton R.B. et al.Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials.
Lancet. 358: 1668-1675Kabbouche M.A. Vockell A.L. LeCates S.L. et al.Tolerability and effectiveness of prochlorperazine for intractable migraine in children.
Pediatrics. 107https://doi.org/10.1542/peds.107.4.e62Trottier E.D. Bailey B. Lucas N. et al.Prochlorperazine in children with migraine: A look at its effectiveness and rate of akathisia.
Am J Emerg Med. 30: 456-463Brousseau D.C. Duffy S.J. Anderson A.C. et al.Treatment of Pediatric Migraine Headaches: A Randomized, Double-Blind Trial of Prochlorperazine Versus Ketorolac.
Ann Emerg Med. 43: 256-262Trottier E.D. Bailey B. Dauphin-Pierre S. et al.Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department.
J Emerg Med. 39: 166-173Chlorpromazine for the treatment of migraine in a pediatric emergency department.
Headache. 54: 335-342Hodgson S.E. Harding A.M. Bourke E.M. et al.A prospective, randomized, double-blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department.
Headache. 61: 603-611Marmura M.J. Silberstein S.D. Schwedt T.J.The acute treatment of migraine in adults: The american headache society evidence assessment of migraine pharmacotherapies.
Headache. 55: 3-20Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.
Am J Emerg Med. 14: 262-264Friedman B.W. Esses D. Solorzano C. et al.A Randomized Controlled Trial of Prochlorperazine Versus Metoclopramide for Treatment of Acute Migraine.
Ann Emerg Med. 52: 399-406Goadsby P.J. Wietecha L.A. Dennehy E.B. et al.Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.
Brain. 142: 1894-1904Croop R. Goadsby P.J. Stock D.A. et al.Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
Lancet. 394: 737-745Dodick D.W. Lipton R.B. Ailani J. et al.Ubrogepant for the Treatment of Migraine.
N Engl J Med. 381: 2230-2241Paruthi S. Brooks L.J. D’Ambrosio C. et al.Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion.
J Clin Sleep Med. 12: 1549-1561Developmental changes in sleep biology and potential effects on adolescent behavior and caffeine use.
Nutr Rev. 72: 60-64Hysing M. Pallesen S. Stormark K.M. et al.Sleep and use of electronic devices in adolescence: Results from a large population-based study.
BMJ Open. 5: 1-7Cajochen C. Frey S. Anders D. et al.Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.
J Appl Physiol. 110: 1432-1438Howatson G. Bell P.G. Tallent J. et al.Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality.
Eur J Nutr. 51: 909-916Bektaş Ö. Uʇur C. Gençtürk Z.B. et al.Relationship of childhood headaches with preferences in leisure time activities, depression, anxiety and eating habits: A population-based, cross-sectional study.
Cephalalgia. 35: 527-537Peris F. Donoghue S. Torres F. et al.Towards improved migraine management: Determining potential trigger factors in individual patients.
Cephalalgia. 37: 452-463Gelfand Amy A. Pavitt Sara Greene Kaitlin et al.High School Start Time and Migraine Frequency in High School Students.
Headache. 59: 1024-1031Goadsby P.J. Holland P.R. Martins-Oliveira M. et al.Pathophysiology of Migraine: A Disorder of Sensory Processing.
Physiol Rev. 97: 553-622Cuvellier J.C. Mars A. Vallée L.The prevalence of premonitory symptoms in paediatric migraine: A questionnaire study in 103 children and adolescents.
Cephalalgia. 29: 1197-1201Karsan N. Bose P. Goadsby P.J.The Migraine Premonitory Phase.
Contin Lifelong Learn Neurol. 24: 996-1008Arca K.N. Halker Singh R.B.Dehydration and Headache.
Curr Pain Headache Rep. 25: 4-9Perry B.G. Bear T.L.K. Lucas S.J.E. et al.Mild dehydration modifies the cerebrovascular response to the cold pressor test.
Exp Physiol. 101: 135-142Kenney E.L. Long M.W. Cradock A.L. et al.Prevalence of inadequate hydration among US children and disparities by gender and race/ethnicity: National Health and Nutrition Examination Survey, 2009-2012.
Am J Public Health. 105: e113-e118Spigt M. Weerkamp N. Troost J. et al.A randomized trial on the effects of regular water intake in patients with recurrent headaches.
Fam Pract. 29: 370-375Khorsha F. Mirzababaei A. Togha M. et al.Association of drinking water and migraine headache severity.
J Clin Neurosci. 77: 81-84Medicine I of. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate.; 2005. doi:10.17226/10925.
Amin F.M. Aristeidou S. Baraldi C. et al.The association between migraine and physical exercise.
J Headache Pain. 19: 83Robberstad L. Dyb G. Hagen K. et al.An unfavorable lifestyle and recurrent headaches among adolescents: The HUNT Study.
Neurology. 75: 712-717Bigal M.E. Liberman J.N. Lipton R.B.Obesity and migraine: A population study.
Neurology. 66: 545-550Varkey E. Cider Å. Carlsson J. et al.Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls.
Cephalalgia. 31: 1428-1438Santiago M.D.S. Carvalho D. de S. Gabbai A.A. et al.Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: A randomized comparative study.
Arq Neuropsiquiatr. 72: 851-855Oskoui M. Pringsheim T. Billinghurst L. et al.Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention.
Neurology. https://doi.org/10.1212/wnl.0000000000008105Powers S.W. Coffey C.S. Chamberlin L.A. et al.Trial of amitriptyline, topiramate, and placebo for pediatric migraine.
N Engl J Med. https://doi.org/10.1056/NEJMoa1610384Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
Pediatr Neurol. 114https://doi.org/10.1016/j.pediatrneurol.2020.09.009Ebrahimi-Monfared M. Sharafkhah M. Abdolrazaghnejad A. et al.Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Restor Neurol Neurosci. 35: 385-393Gonçalves A.L. Ferreira A.M. Ribeiro R.T. et al.Research paper: Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.
J Neurol Neurosurg Psychiatry. 87: 1127Sazali S. Badrin S. Norhayati M.N. et al.Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.
BMJ Open. 11https://doi.org/10.1136/BMJOPEN-2020-039358von Luckner A. Riederer F.Magnesium in Migraine Prophylaxis—Is There an Evidence-Based Rationale? A Systematic Review.
Headache J Head Face Pain. 58: 199-209Szperka C.L. VanderPluym J. Orr S.L. et al.Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.
Headache. 58https://doi.org/10.1111/head.13414Greene K.A. Gentile C.P. Szperka C.L. et al.CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.
Pediatr Neurol. 114: 62Hershey A.D. Lin T. Gruper Y. et al.Remote electrical neuromodulation for acute treatment of migraine in adolescents.
Headache. 61: 310-317Chou D.E. Shnayderman Yugrakh M. Winegarner D. et al.Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
Cephalalgia. 39: 3-14Grazzi L. Egeo G. Liebler E. et al.No Title.
Neurol Sci. 38: S197-S199Irwin S.L. Qubty W. Allen I.E. et al.Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.
Headache. 58: 724-731Yarnitsky D. Volokh L. Ironi A. et al.Nonpainful remote electrical stimulation alleviates episodic migraine pain.
Neurology. 88: 1250-1255Ailani J. Burch R.C. Robbins M.S.The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.
Headache. 61: 1021-1039Ernst M.M. O’Brien H.L. Powers S.W.Cognitive-behavioral therapy: How medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine.
Headache. 55: 1382-1396Power S.W. Kashikar-Zuck S.M. Allen J.R. et al.Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial.
JAMA. 310: 2622-2630Kroner J.W. Hershey A.D. Kashikar-Zuck S.M. et al.Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 per Month.
Headache. 56: 711-716Stubberud A. Tronvik E. Olsen A. et al.Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.
Headache. 60: 889-901Minen M.T. Adhikari S. Padikkala J. et al.Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.
Headache. 60: 2232-2246Szperka C.L. Gelfand A.A. Hershey A.D.Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section.
Headache. 56: 1597-1607Gelfand A.A. Reider A.C. Goadsby P.J.Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.
Pediatr Neurol. 50: 135-139Robbins M.S. Robertson C.E. Kaplan E. et al.The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.
Headache. 56: 240-258Cady R. Saper J. Dexter K. et al.A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360® as acute treatment for chronic migraine.
Headache. 55: 101-116Binfalah M. Alghawi E. Shosha E. et al.Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.
Pain Res Treat. 2018https://doi.org/10.1155/2018/2516953Mousa M.A. Aria D.J. Mousa A.A. et al.Sphenopalatine ganglion nerve block for the treatment of migraine headaches in the pediatric population.
Pain Physician. 24: E111-E116Kouri M. Somaini M. Cárdenas V.H.G. et al.Transnasal sphenopalatine ganglion block for the preventive treatment of chronic daily headache in adolescents.
Children. 8: 1-8The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review.
J Child Neurol. 35: 844-851Goenka A. Yu S.G. George M. et al.Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population.
Neuropediatrics. https://doi.org/10.1055/A-1832-9168Ali S.S. Bragin I. Rende E. et al.Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients.
Cureus. 11https://doi.org/10.7759/CUREUS.4343Shah S. Calderon M.D. Crain N. et al.Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population.
Reg Anesth Pain Med. 46: 41-48Goenka A. Grace Yu S. Chikkannaiah M. et al.Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.
Pediatr Neurol. 130: 21-27
留言 (0)